SUN PHARMACEUTICAL INDUSTRIES INC recalls Perampanel CIII Tablets
- Recalling company
- SUN PHARMACEUTICAL INDUSTRIES INC
- Product
- Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6
- Reason
- Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 17, 2026
- Reported
- Jul 1, 2026
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 3,456 30-count bottles
- Lot / codes
- Lot AE01763, Expires 9/30/2027.
- Company location
- Princeton, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0628-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0628-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.